Cagrilintide+Semaglutide: Handling, Storage, and Reconstitution Guide

This Cagrilintide+Semaglutide handling and storage guide covers lab best practice for working with the amylin and incretin blend as a lyophilized research material. It covers reconstitution for in vitro prep, cold-chain storage, aliquoting, and record keeping for both peptide parts. All of it is framed as lab procedure, not any form of administration.

How should lyophilized Cagrilintide+Semaglutide be stored?

Store the lyophilized blend sealed at or below 25 degrees Celsius, away from heat, light, and moisture. It ships as a solid, white, freeze-dried powder in a sealed glass vial. The 5+5 mg format pairs the two parts in one batch. For long-term storage, keep it dry and refrigerated or frozen. This keeps both peptides stable for the whole study.

Steady conditions are part of quality assurance. Swings in heat or humidity can harm the material and make results harder to repeat.

This is a blend, so good storage protects two molecules at once. The same cold-chain habits apply to each part on its own. See the Cagrilintide handling guide and the Semaglutide handling guide.

How is the blend reconstituted for in vitro work?

For in vitro work, the blend is reconstituted with bacteriostatic water. Add the water slowly down the vial wall. Then swirl gently rather than shaking, since hard shaking can stress peptides. Prepare it under clean conditions with calibrated pipettes and suitable PPE.

The vial holds both peptides. So adding water dissolves both together at their fixed ratio. The two arms cannot be separated at this stage. Record the total peptide mass along with the split between the two parts.

The working concentration should follow the assay design, not a fixed formula. Use both molecular weights to convert between mass and molar concentration for each part:

• Cagrilintide: about 4409.01 g/mol
• Semaglutide: about 4113.64 g/mol

This is reagent prep for lab assays, not a route of administration. Concentration choices tie back to the models in the Cagrilintide+Semaglutide research applications.

Why should the reconstituted blend be aliquoted?

Single-use aliquots limit repeated freeze-thaw cycles, which can break peptides down over time. Label each aliquot with these details:

• Blend name and component ratio
• Total concentration
• Lot numbers
• Date

Log the storage location so the cold chain stays auditable.

Both parts carry fatty chains that bind albumin, which supports long stability studies. So intact aliquots are especially useful for the time-course work in the Cagrilintide+Semaglutide mechanism of action. There, consistent starting material keeps longer experiments comparable. Keep the reconstituted peptide refrigerated. Use it within the time frame set by your protocol.

Plan aliquot volume around the assay. Size each aliquot for one experiment. This avoids partial thaws and keeps the fixed ratio intact from vial to bench. The two peptides are dispensed together. So a plan that never refreezes a thawed portion protects both arms equally. It also preserves the paired signal the blend is meant to support.

How should the vial be checked on receipt?

Inspect the vial before storing it. Check three things:

• The seal is intact.
• The powder is an even white cake, with no color change or clumping.
• The label matches the paperwork for the 5+5 mg blend.

Log the arrival date. Move the vial into cold storage promptly, so the cold chain is unbroken from delivery to bench.

Record any problem before the material enters a study. Examples include a broken seal, signs of warm transit, or a label that does not match the paperwork. Both peptides in the blend are sensitive to the same stresses. Recording the vial's condition on arrival gives the batch record a clean starting point. It also makes later questions about repeat results easier to answer.

What does the certificate of analysis show for both parts?

Each batch ships with a third-party-verified certificate of analysis, or COA. The COA lists:

• Purity by HPLC or reverse-phase chromatography
• Identity of both peptide parts, confirmed by mass spectrometry
• Lot number, test date, and method details

Two peptides are present. So check that the COA confirms identity and purity for each one, not just a combined figure.

Record the lot number with results. This ties data to a specific batch and supports repeatable results. Sample COAs (PDF) can be requested before purchase. They confirm test parameters and batch consistency for both parts. Independent checks are encouraged. Material and records are on the Cagrilintide+Semaglutide product page.

What safety and compliance rules apply?

Handle the blend as a research chemical. Follow these rules:

• Only qualified staff should handle it.
• Keep local SOPs and chemical hygiene plans in force.
• Use engineering controls where required.
• Dispose of waste per local and applicable rules.

Record lot numbers, storage conditions, and handling steps. Keep batch records for both parts to support traceability and audit readiness.

Steady storage and complete records for the whole study support reliable, repeatable results. They also keep the lab ready for review. The blend combines two long-acting analogs. So the safest default is treating both as equally sensitive to heat, light, and moisture.

Traceability takes more work for a blend than for a single peptide, because two lot histories meet in one vial. Keep the certificate of analysis, the component ratio, and both lot numbers together in the batch record. Then a reviewer can rebuild exactly what was on the bench for any result. That is the base of repeatable work with a two-part research material.

For research use only. Cagrilintide+Semaglutide is an investigational research peptide blend and is not approved for human or veterinary use. All handling guidance refers to laboratory procedure only.